Respiratory Strategic Roundup | Sep 04- Oct 07, 2026

From September 4 to October 7, 2026, respiratory market developments pointed toward a broader shift from chronic maintenance toward acute intervention, prevention, earlier treatment, localized delivery and disease modification. This Strategic Roundup explores the major strategic themes shaping asthma, respiratory delivery platforms, rare and progressive lung disease, and earlier intervention opportunities. Watch the full Strategic Roundup for deeper strategic analysis of how these shifts may reshape competitive positioning